A clinical trial to compare different doses of mosunetuzumab in people with systemic lupus erythematosus (SLE)

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus

Autoimmune Disorder
Systemic Lupus Erythematosus

Results
Download

Study results

LPS GA43191 MOSUN Final Results August 2025 English (PDF, 0.8 MB)

LPS GA43191 MOSUN Final Results August 2025 Polish (PDF, 0.7 MB)

LPS GA43191 MOSUN Final Results August 2025 Romanian (PDF, 0.7 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A clinical trial to compare different doses of mosunetuzumab in people with systemic lupus erythematosus (SLE)

Study results

LPS GA43191 MOSUN Final Results August 2025 English (PDF, 0.8 MB)

LPS GA43191 MOSUN Final Results August 2025 Polish (PDF, 0.7 MB)

LPS GA43191 MOSUN Final Results August 2025 Romanian (PDF, 0.7 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A clinical trial to compare different doses of mosunetuzumab in people with systemic lupus erythematosus (SLE)

For the latest version of this information please go to www.forpatients.roche.com